Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for ELETRIPTAN

Ingredient

ELETRIPTAN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
RELPAX	40MG	TABLET	Resolved	2025-02-12	2025-03-03	250228
RELPAX	40MG	TABLET	Resolved	2023-06-13	2023-08-16	194835
RELPAX	40MG	TABLET	Resolved	2019-07-31	2019-12-20	90386
RELPAX	20MG	TABLET	Resolved	2023-05-25	2023-07-13	193008
TEVA-ELETRIPTAN	40MG	TABLET	Resolved	2020-05-29	2021-02-25	116156
TEVA-ELETRIPTAN	40MG	TABLET	Resolved	2018-03-13	2018-05-11	42553
TEVA-ELETRIPTAN	40MG	TABLET	Resolved	2017-08-01	2017-10-10	17887
TEVA-ELETRIPTAN	20MG	TABLET	Actual shortage	2026-01-15	2026-01-22	276245
TEVA-ELETRIPTAN	20MG	TABLET	Resolved	2025-06-13	2025-08-08	260257
TEVA-ELETRIPTAN	20MG	TABLET	Resolved	2020-10-01	2021-01-14	125500

Previous
1
2
3
4
5
Next

Showing 31 to 40 of 42

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
PMS-ELETRIPTAN	20MG	TABLET	Discontinued	2020-06-15	2021-10-27	117933
PMS-ELETRIPTAN	40MG	TABLET	Discontinued	2020-06-17	2020-06-17	118162
PMS-ELETRIPTAN	40MG	TABLET	Discontinued	2020-06-17	2020-06-17	118165

1

Showing 1 to 3 of 3